NCT04299230View on ClinicalTrials.gov

Continous Monitoring of Vital Signs on Hospitalized Cancer Patients.

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

February 1, 2016

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
CancerFever
Interventions
DEVICE

Cortium C3

Trial Locations (2)

4700

Naestved Hospital, Næstved

Næstved

All Listed Sponsors
lead

Naestved Hospital

OTHER

NCT04299230 - Continous Monitoring of Vital Signs on Hospitalized Cancer Patients. | Biotech Hunter | Biotech Hunter